Type 2 diabetes is a condition where the body cannot properly control blood sugar levels. It happens when cells become resistant to the effects of insulin. Insulin is the hormone made in the pancreas that allows cells to use glucose from food for energy.
Over time, the pancreas makes less insulin, and blood sugar levels keep rising. This causes damage to the body’s organs like the heart, kidneys, eyes, and nerves. Managing type 2 diabetes requires medications and lifestyle changes to control blood sugar. But even then, many patients struggle to regulate their diabetes. This has led scientists to look for innovative new solutions, like stem cell therapy.
Stem cells have the special ability to develop into many different cell types in the body. One promising idea is to use stem cells from the umbilical cord to regenerate insulin-producing cells. This could potentially cure type 2 diabetes.
Research shows that as type 2 diabetes progresses, it slowly destroys the insulin-producing beta cells in the pancreas. Scientists think stem cell transplantation may replace these damaged cells. This would restore normal levels of insulin to control blood sugar.
Mesenchymal stem cells (MSCs) obtained from discarded umbilical cords seem ideally suited for this task. MSCs can painlessly and ethically be harvested after birth without harming the baby.
In the lab, MSCs can be grown in large numbers. They can also be changed into insulin-secreting beta-like cells. When injected back into the patient, these new cells could repopulate the damaged pancreas. The stem cells would effectively take over the work of the previously destroyed beta cells.
Additionally, chemicals secreted by MSCs stimulate regeneration of the patient’s existing pancreas tissue. This helps revive their natural insulin production. Early research shows MSCs may also directly regulate blood sugar through other helpful effects in the body.
Exciting research in both animals and humans demonstrates how MSCs may successfully treat type 2 diabetes.
A recent study showed remarkable effects when diabetic lab animals received MSC treatment. The animals’ insulin output and blood sugar levels improved back to normal. The transplanted stem cells regenerated the pancreas’ ability to make insulin by turning into new beta cells. This effect was even stronger with MSCs collected from human umbilical cords compared to bone marrow stem cells.
Multiple early clinic trials also confirm benefits in actual diabetes patients who agreed to test MSC transplantation. The patients showed better control of blood sugar markers like glycated hemoglobin (HbA1c) and fasting glucose levels. HbA1c provides an average blood sugar reading over the past 3 months.
In one 2011 experiment, over half the type 2 diabetes patients who got placental stem cells injected used less insulin and had lower HbA1c at 3-6 months. Another study gave bone marrow stem cells to patients recently diagnosed with type 2 diabetes. After one year their HbA1c, fasting blood sugar, and a marker of natural insulin secretion all substantially improved compared to similar patients not given stem cells.
Promising animal research reveals stem cell therapy does more than just regulate blood sugar. Mice with diabetes treated using fat tissue MSCs showed less eye, nerve and kidney injury versus untreated diabetic mice. This means MSC injections could potentially protect patients from diabetes-related organ damage in the long run.
While still investigative, many researchers are increasingly positive regarding MSCs’ future potential. To take things to the next step, rigorous testing is underway to confirm initial successes.
Several trials led by the Stem Cell Medical Center aim specifically to test an innovative stem cell treatment protocol in actual patients with type 2 diabetes.
The Stem Cell Medical Center is located in Antigua and provides cellular therapy to patients from around the world. Their clinical trials ethically obtain MSCs from healthy volunteers instead of discarded umbilical cord tissue.
The study will explore the potential of using mesenchymal stem cells (MSCs) to improve long-term outcomes for diabetes patients. This includes investigating the optimal dosage for such treatment and closely monitoring participants to assess its effectiveness in achieving sustained blood sugar control with reduced medication needs and preventing diabetic complications.
If larger clinical trials validate the current promising results, MSCs could become a simple, safe, and permanent solution for type 2 diabetes. Patients may be able to reverse high blood sugar early on before permanent damage is done.
For the millions struggling to manage diabetes daily, stem cell therapy might just be the glimmer of hope they awaited. The Stem Cell Medical Center welcomes inquiries from patients wishing to enroll in upcoming clinical trials of this innovative cellular treatment for diabetes.
If you or a loved one suffers from type 2 diabetes, contact the Stem Cell Medical Center today to learn more about our stem cell clinical trials. This cutting-edge therapy could potentially transform your life by reversing uncontrollable blood sugars for good.
Contact us and schedule a consultation to see if you may benefit from regenerative treatments. Stem cell therapy could alleviate your pain and help you regain mobility.